Insights Into Timing, Risk Factors, and Outcomes of Stroke and Transient Ischemic Attack After Transcatheter Aortic Valve Replacement in the PARTNER Trial (Placement of Aortic Transcatheter Valves) [Structural Heart Disease]

Conclusions— Risk of stroke or TIA is highest early after TAVR and is associated with increased 1-year mortality. Modifications of TAVR, emboli-prevention devices, and better intraprocedural pharmacological protection may mitigate this risk. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT00530894.

http://circinterventions.ahajournals.org/cgi/content/short/9/9/e002981?rss=1

Source: Circulation: Cardiovascular Interventions - September 5, 2016 Category: Cardiology Authors: Kapadia, S., Agarwal, S., Miller, D. C., Webb, J. G., Mack, M., Ellis, S., Herrmann, H. C., Pichard, A. D., Tuzcu, E. M., Svensson, L. G., Smith, C. R., Rajeswaran, J., Ehrlinger, J., Kodali, S., Makkar, R., Thourani, V. H., Blackstone, E. H., Leon, M. B. Tags: Aortic Valve Replacement/Transcatheter Aortic Valve Implantation, Transient Ischemic Attack (TIA) Structural Heart Disease Source Type: research